StockData

Vivos Inc (RDGL) stock

RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$0.05−0.00 (-2.51%)

Close on Oct 19, 2026Market cap $23.61MP/E –Yield –

Earnings

Vivos's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Vivos's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2013ended Dec 31, 2013Jan 16, 2014after the close–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Vivos has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Vivos puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Vivos filed with the SEC as exhibits to Form 8-K or 6-K

  1. Inc. Reports Encouraging Human Clinical Trial Results and Announces Expansion Plans
    News
  2. Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials
    News
  3. provisional patent on the chiller and related equipment expires on 12/30/23 so we authorized Indiano Law Group to file for a utility
    News
  4. Inc. Provides 2021 Recap and Outlines 2022 Objectives
    News

See a number that looks wrong?